Harmony Biosciences Holdings, Inc.
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
HRMY$33.78+2.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
| | Page |
|---|---|
| Part I | 3 |
| CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS | 3 |
| ITEM 1. BUSINESS. | 5 |
| ITEM 1A. RISK FACTORS. | 26 |
| ITEM 1B. UNRESOLVED STAFF COMMENTS. | 73 |
| ITEM 1C. CYBERSECURITY | 73 |
| ITEM 2. PROPERTIES. | 76 |
| ITEM 3. LEGAL PROCEEDINGS. | 76 |
| ITEM 4. MINE SAFETY DISCLOSURES. | 76 |
| Part II | 77 |
| ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES. | 77 |
| ITEM 6: [RESERVED] | 78 |
| ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. | 78 |
| ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. | 90 |
| ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA. | 90 |
| ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE. | 122 |
| ITEM 9A. CONTROLS AND PROCEDURES. | 123 |
| ITEM 9B. OTHER INFORMATION. | 123 |
| ITEM 9C. DISCLOSURES REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS | 124 |
| Part III | 125 |
| ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE. | 125 |
| ITEM 11. EXECUTIVE COMPENSATION. | 125 |
| ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS. | 125 |
| ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE. | 125 |
| ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES. | 125 |
| Part IV | 126 |
| ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES. | 126 |
| SIGNATURES | 130 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.